Browsing Tag
Eli Lilly
20 posts
Eli Lilly is making a game-changing move in healthcare with a $3.2 billion acquisition! 💊
Eli Lilly plans to acquire Morphic Therapeutics, a biotechnology company, for $3.2 billion in an all-cash deal. Morphic,…
Finally! A New Hope for Alzheimer’s Patients – FDA Approves Kisunla 🙌
The FDA approved a new Alzheimer’s drug, Kisunla, from Eli Lilly, following unanimous recommendation by an expert panel.…
Altimmune’s obesity drug shows jaw-dropping 15.6% weight loss – could this be the future of weight loss? 💊
Positive Clinical Trial Results Propel Altimmune Altimmune (ALT) has recently caught the attention of investors, with its stock…
Amphastar’s product portfolio is thriving – discover how this pharma giant is conquering new markets!
Amphastar Pharmaceuticals is experiencing a bullish trend reversal following their strong Q1 2024 financial performance. The company reported…
Revolutionizing Drug Discovery: The Rise of AI in Pharmaceutical Innovation
Innovation knows no bounds, especially in the realm of pharmaceuticals. Eli Lilly (LLY), a stalwart in the industry,…
Mounjaro & Zepbound Drive Eli Lilly’s Revenue Sky-High in Q1
Eli Lilly has reported a strong performance in the first quarter of 2024, continuing the momentum from 2023…
